WO2002082924A1 - Microcapsules - Google Patents
Microcapsules Download PDFInfo
- Publication number
- WO2002082924A1 WO2002082924A1 PCT/DK2002/000238 DK0200238W WO02082924A1 WO 2002082924 A1 WO2002082924 A1 WO 2002082924A1 DK 0200238 W DK0200238 W DK 0200238W WO 02082924 A1 WO02082924 A1 WO 02082924A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pectin
- matrix material
- pectic substance
- treating
- obtainable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/72—Encapsulation
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/231—Pectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to microcapsules comprising an active substance embedded in a novel type of matrix material, a process of preparing such microcapsules and products comprising the microcapsules.
- Naturally occurring and modified polysaccharides and naturally occurring hydrocolloids such as alginate, carrageenan, gelatine, pectins, gum arabic and acacia gum, find wide spread use as matrix materials for the microencapsulation of sensitive active substances such as vitamins and aroma and flavour substances in food, food supplements, pharmaceuticals and agricultural products in order to protect them against influences of oxygen, moisture and irradiation as well as physical influences and thus to avoid chemical and/or physical degradation of said active substances and to improve their storage stability.
- hydrocolloids presently used as matrix materials are mainly of animal origin, e.g. gelatinous materials from mammals and fish.
- microencapsulated products based on the use of matrix materials of animal origin are unacceptable for use in some products such as vegetarian foods, kosher foods and halal foods.
- the legislation governing the use of food products of animal origin is likely to become stricter in the future.
- pectic substances such as citrus or sugar beet pectin only offer a limited protection of microencapsulated active substances against degradation and thus do not provide microencapsulated products with a desired storage stability.
- European patent application No. 1 066 761 discloses encapsulated compositions comprising a fat-soluble substance encapsulated in a carbohydrate matrix composed of maltose or maltose syrup or a mixture of low-molecular weight carbohydrates, such as maltodexthn, optionally in combination with a high-molecular weight carbohydrate, an emulsifier and optionally an antioxidant.
- US patent No. 5 998 176 discloses a method of causing gelling or increase of viscosity of an aqueous medium containing a pectic material such as sugar beet pectin by treating the aqueous medium with a carboxylic ester hydrolase and an oxidase and/or a peroxidase in the presence of an oxidizing agent for use with said oxidase and/or peroxidase. It is mentioned that the resulting gelled or viscous products are suitable, e.g. as thickening and/or stabilizing agents in foodstuff applications, as a material for drug encapsulation in medical/medicinal applications and as a slow release vehicle in both medical/medicinal and agricultural/horticultural applications.
- Danish Patent Application 1991 01060 discloses unbranched arabans, e.g. from sugar beet, obtained by treatment of sugar beet araban with ⁇ -L- arabinofuranosidase, and their use as gelling agents, as emulsifiers and as encapsulating material.
- the sugar beet arabans used as enzyme substrate in that process are obtained by an alkaline treatment of sugar beet pulp, and the raw sugar beet arabans comprises typical about 70-85 % arabinose, 5-10 % uronic acid, 8-15 % D-galactose, and a few % rhamnose and other monosaccharides.
- WO 00/70967 A1 discloses a composition comprising colouring substance bodies that are at least partially coated with unmodified pectin selected from beet pectin, chicory pectin and Jerusalem artichoke, preferable with a high degree of acetylation.
- WO 00/17368 discloses an orange fruit pectin acetyl esterase and a process wherein the esterase is contacted with a substrate, such as pectin from a fruit or a vegetable. Improved gelling properties are obtained by deacetylating sugar beet pectin with the disclosed acetyl esterase.
- the object of the present invention is to provide microcapsules comprising a matrix material of non-animal origin and being capable of effectively protecting active substances embedded in the matrix material against chemical and physical influences.
- microcapsules according to the invention are characterized in that the matrix material is obtainable by treating a pectic substance with one or more enzymes selected from the group consisting of esterases (E.C.3.1 ), glucosidases (E.G.3.2), peptidases (E.C.3.4), proteases (E.G.3.4) and lyases (E.C.4).
- esterases E.C.3.1
- glucosidases E.G.3.2
- peptidases E.C.3.4
- proteases E.G.3.4
- lyases E.C.4
- microcapsules of the invention compared to microcapsules comprising a matrix material of non- modified pectin will appear from the drawings in which
- Fig. 1 shows stability test results obtained by storage of microcapsules at a temperature of 25 °C and 60 % RH
- Fig. 2 shows stability test results obtained by storage of microcapsules at a temperature of 40 °C and 75 % RH.
- Figs. 1 and 2 show curves illustrating the potency of microcapsules containing vitamin A palmitate embedded in various matrix materials as a function of time.
- microcapsules according to the invention viz. comprising matrix material being protease treated pectin, shaved ⁇ - pectin, deacetylated ⁇ -pectin, rhamnogalacturonase treated ⁇ -pectin, lyase treated ⁇ -pectin, carboxypeptidase A or B treated ⁇ -pectin, and Flavourzyme 500L TM treated ⁇ -pectin as well as lyase treated orange pectin exhibit significantly better stabilities when stored both at 25 °C, 60% RH and at 40 °C, 75% RH for periods up to at least 20 days than microcapsules comprising non-modified pectin as matrix material. 5
- microcapsules as used herein means particles each comprising a matrix material having embedded therein a plurality of solid or liquid micro particles.
- Pectins also comprise "smooth regions" which are rigid regions in which the backbone consists essentially of galacturonic acid or galacturonic acid residues having very small side chains such as methyl or ethyl groups.
- pectic substance encompasses pectin, pectic acid and salts and esters of pectic 25 acid (pectates), whereby the pectic substance has a galacturonic acid content of above 40 %.
- the galacturonic acid content of the pectic substance is preferable above 50 % and more preferred above 65 %.
- the matrix material of the microcapsules of the invention preferably consists of pectin, which has been treated with one or more enzymes capable of modifying of the hairy regions, viz. the side chains of the rhamnogalacturonan backbone of the pectin.
- enzymes capable of modifying of the hairy regions, viz. the side chains of the rhamnogalacturonan backbone of the pectin.
- Preferred examples of such enzymes are rhamnogalacturonase, rhamnogalacturonan acetyl esterase, ⁇ -galactosidase, arabinanase, galactanase and ⁇ -arabinofuranosidase.
- Another preferred matrix material is a pectin which has been treated with one or more enzymes capable of modifying the backbone of the smooth regions of pectin so as to form separate elements comprising hairy regions.
- enzymes examples include pectin lyase and combinations of polygalacturonase and pectin methyl esterase.
- pectins contain proteins, e.g. in an amount of about 1-5% w/w and surprisingly it has been found that the protective properties of such protein- containing pectins are significantly improved, if they are treated with a protease such as papain, pepsin and trypsin.
- a protease such as papain, pepsin and trypsin.
- the pectic material to be modified according to the invention is preferably derived from beetroot (Beta vulgaris L. Chenopodiaceae), including sugar beet, garden beet (red beet), chard, ⁇ , spinach beet, silver beet and fodder beet, or from orange, grape, soybean, linseed, Jerusalem artichoke, celery, and potatoes.
- Sugar beet pectin is a particularly useful pectic substance.
- Esterases constituting a subclass to hydrolases (E.G.3) are enzymes that catalyse the hydrolysis of ester groups of pectin.
- Preferred esterases for use for the modification of pectic substances are deacetylating enzymes, such as rhamnogalacturonan-acetylesterase, pectin acetyl esterase, and pectin methyl esterase.
- Glucosidases (E.C.3.2), also constituting a subclass to hydrolases (E.G.3), are enzymes, which catalyse the hydrolysis of glycosidic bonds in pectin.
- Preferred glucosidases are debranching enzymes, such as ⁇ - arabinofuranosidase, galactanase, arabinanase, and endo- and exo- polygalacturonases.
- ⁇ - arabinofuranosidase ⁇ - arabinofuranosidase
- galactanase galactanase
- arabinanase endo- and exo- polygalacturonases.
- a mixture of ⁇ -arabinofuranosidase, galactanase, rhamnogalacturonase, and arabinanase is particularly useful.
- Peptidases and proteases (E.C.3.4), which also constitute a subclass to hydrolases, (E.C.3) catalyse the hydrolysis of peptide bonds.
- Preferred proteases are papain, pepsin and trypsin (endopeptidases), and carboxypeptidase A and B (exopeptidases), as well as combinations of endo- and exopeptidases, such as Flavorzyme 500L TM.
- proteases examples include Papain 16000 from Valley Research and Collupulin® from DSM Gist-Brocades Food Specialities.
- Lyases are enzymes, which catalyse addition to double bonds.
- a preferred lyase is pectinase PL lyase.
- deacetylating enzyme means an enzyme that is capable of removing acetyl groups, which are covalently bonded to galacturonic acid residues in the backbone of the hairy regions of pectin.
- cutting enzyme or "debranching enzyme” mean enzymes which are capable of reducing the length of the side chains of the hairy regions of pectin.
- pectin esterase means an enzyme, which is capable of removing ester residues from galacturonic acid residues in the backbone of pectin.
- the enzymatic modification of pectic substances may be carried out as follows: Temperature and pH of the pectin preparation are adjusted to working temperature and pH of the enzyme to be used, respectively. Enzyme is dissolved/diluted in ion exchanged water and added to the pectin preparation. Reaction is carried out while stirring continuously, and if necessary pH is controlled by titration. After a certain time reaction is terminated by lowering pH. In order to irreversibly inactivate the enzyme, temperature is raised to 80°C for 10 min. Temperature of the solution is lowered and the pectin is precipitated (1 :3) in 80% 2-propanol. The precipitated pectin is drained on a belt press and put in a drying cabinet at 70°C for 24 hours. After drying the pectin is ground and sieved (DIN 24).
- the pectin preparation to be used as substrate for enzyme treatment can be an extract directly obtained from the raw material e.g. sugar beet peel or it can be a solution of a refined pectin product.
- An extract of sugar beet pectin may be prepared as follows:
- a pectin solution is made by adding pectin powder to hot (70°C) ion- exchanged water. The preparation is stirred continuously, until the pectin is completely dissolved.
- the active substances contained in the microcapsules of the present invention may be any substance, which during storage, transport, handling and use requires protection, e.g. from oxygen, moisture, light radiation, and physical influences, in order to avoid physical and chemical decomposition of the substance. These active substances are further defined as being active in either a chemical or biological system.
- a protective matrix may be used to prevent the active substance from reacting with other substances present in a composition or with substances with which it may come into contact during use and which would have a deleterious affect upon the active substance's desired activity.
- a protective matrix may be used to transform liquids and other substances, which are difficult to handle, e.g. due to stickiness, into a solid form suitable for handling and processing during use, such as a powder of microcapsules.
- active substances suitable for use in the present invention are fat-soluble substances, such as vitamins, fatty acids, e.g. mono- and polyunsaturated fatty acids, which may be added in the form of fish oil containing i.a. the (n-3) fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), and in the form of evening primrose oil and castor oil containing i.a. the (n-6) fatty acid ⁇ -linolenic acid, carotenoides, e.g.
- vitamins fatty acids
- DHA docosahexaenoic acid
- EPA eicosapentaenoic acid
- EPA eicosapentaenoic acid
- carotenoides e.g.
- ⁇ -caroten lutein, lycopene, ⁇ -cryptoxanthin and zeaxanthin, oils and fats
- water-soluble substances such as vitamin C
- enzymes e.g. amylase
- pharmaceuticals such as griseofulvin, ibuprofen, benzodiazepines, phenacetin, hormones and paracetamol
- other nutritional supplements such as minerals.
- Additional active substances are aroma and flavour compounds.
- the matrix material of the microcapsules of the invention may contain conventional additives such as antioxidants, e.g. t-butylhydroxyloluene (BHT), t-butylhydroxyanisole (BHA), ascorbic acid, ascorbyl palmitate, sodium ascorbate, tocopherols, TBHQ, ethoxyquine, propyl gallate, and extracts from herbs, i.a. rosemary extract; powdering agents, e.g.
- antioxidants e.g. t-butylhydroxyloluene (BHT), t-butylhydroxyanisole (BHA), ascorbic acid, ascorbyl palmitate, sodium ascorbate, tocopherols, TBHQ, ethoxyquine, propyl gallate, and extracts from herbs, i.a. rosemary extract
- powdering agents e.g.
- starches modified starches, tri-calcium phosphate, lactose, mannitol, ethylcellulose, coagulated albumin, hardened gelatine, casein, stearat-Ca, stearat-Na, metal soaps, hydrogenated ricinus oil, polyoxide, talcum, waxes, and silicates; anti- caking agents, e.g. t -calcium phosphate and silicates, i.a. silicon dioxide and sodium aluminium silicate; plasticizers, e.g.
- carbohydrates and carbohydrate alcohols examples of which are saccharose, glucose, fructose, lactose, invert sugar, sorbitol, mannitol, maltodextrin, glycerin, and mixtures thereof, preferably saccharose, lactose, maltodextrin, and mixtures thereof.
- the invention also relates to a process of preparing microcapsules containing an active substance embedded in a matrix which process comprises the steps of providing an aqueous medium of a pectic substance modified by treatment with one or more enzymes selected from the group consisting of esterases (E.C.3.1 ), glucosidases (E.G.3.2), peptidases (E.G.3.4), proteases (E.C.3.4), and lyases (E.G.4), adding to said solution at least one active substance, finely dividing and drying the mixture thus obtained to obtain a mass of particles each containing a plurality of liquid or solid micro particles of the active substance embedded in a matrix comprising a modified pectic substance.
- esterases E.C.3.1
- glucosidases E.G.3.2
- peptidases E.G.3.4
- proteases E.C.3.4
- lyases E.G.4
- the final step of the above process may be carried out with conventional methods such as spray cooling, spray drying, modified spray drying or sheet drying and crushing, cf. WO 91/06292.
- the present invention also relates to products comprising the microcapsules described above.
- Typical examples of such products are foods, food supplements, beverages, pharmaceutical and veterinary products, feeds, feed supplements, personal care products and household products.
- the molecular weight (MW) is measured by the Capillary Tube Method principle as follows: The outlet time is measured for a pectin/hexametaphosphate solution and the molecular weight is thereafter calculated after a well-known formula (see WO 00/58367 Pectin having reduced calcium sensitivity, page 12).
- the outlet time is measured on two outlets. If the difference between the times is more than 0.4 seconds the measuring is repeated until the difference is less than the appropriate value.
- the outlet time used for the molecular determination is the mean value of the above-mentioned identical or substantially identical measuring results.
- pectic substance was derived from sugar beets (GENU beta pectin, lot 92455, produced by CP Kelco ApS, Lille Skensved, Denmark) and the enzyme was papain (Collupulin® papain batch R9741 , produced by DSM Gist-Brocades Food Specialities, Delft, The Netherlands).
- the pectic substance was derived from sugar beets (GENU® beta pectin, lot 82899, produced by CP Kelco ApS, Lille Skensved, Denmark).
- the enzymes used were ⁇ -arabinofuranosidase ( ⁇ -ARA) (batch sp 580, PPJ 4494), arabinanase (batch sp 564, PPJ 4381 ) and galactanase (batch sp 518 PPJ 4368), all produced by Novo Nordisk, Bagsvaerd, Denmark.
- the pectic substance was derived from sugar beets (GENU® beta pectin, lot 92455 produced by CP Kelco ApS, Lille Skensved, Denmark) and the enzyme was rhamnogalacturonan acetyl esterase (batch PPJ 4456, produced by Novo Nordisk, Bagsvaerd, Denmark).
- 50 I of ion-exchanged water was heated to 70 °C, and 1 kg of pectic substance was added, while stirring continuously. The temperature was lowered to 50 °C, and pH was adjusted to 4.50 by titration with a 2% (w/v) NH 3 solution.
- the pectic substance was derived from sugar beets (GENU® beta pectin, lot 82899 produced by CPKelco ApS, Lille Skensved, Denmark) and the enzyme was rhamnogalacturonase (Batch PPJ 4478, produced by Novo Nordisk, Bagsvaerd, Denmark).
- 50 I of ion-exchanged water was heated to 70 °C, and 1 kg of pectic substance was added, while stirring continuously. The temperature was lowered to 50 °C, and pH was adjusted to 4.50 by titration with a 2% (w/v) NH 3 solution.
- the pectic substance was derived from sugar beet (Batch no. 30003, Type SF H-25, produced by CPKelco, Germany GmbH, Grossenbrode, Germany) and the enzyme was Enzeco Pectinase PL lyase from Enzyme Development Corporation, Batch no. S-11677, Activity 26 U/ml.
- the temperature was raised to 80 °C. After 10 minutes at 80 ° C, the solution was cooled to 50 ° C, evaporated to half amount by the following procedure: The solution was transferred to the evaporator. Heat was applied under vacuum at 0.8 bar, and the solution will reach the boiling point (around 60 ° C). The solution was cooled to 50 ° C and the modified pectin was precipitated (1 :3) in 80% 2-propanol. The precipitated pectin was drained on a belt press and put into a drying cabinet at 70 ° C for 24 hours. After drying, the pectin was ground and sieved (DIN 24). Degree of acetylation (% D(Ac)), degree of esterification (% DE). Galacturonic acid (%GA) and molecular weight (MW) of the enzyme treated pectin were determined and the result appears in Table 5:
- pectic substance was derived from sugar beets (GENU Beta pectin, lot 30003, produced by CP Kelco, Germany GmbH, Grossenbrode, Germany) and the enzyme was Carboxypeptidase B from Sigma, Batch no. 108H7406, activity 176u/mg
- pectic substance was derived form sugar beets (GENU Beta pectin, lot 30003, produced by CPKelco, Germany GmbH , Grossenbrode, Germany) and the enzyme was Carboxypeptidase A from Sigma, Batch no. 127H7445, activity 50u/mg.
- pectic substance was derived from sugar beets (GENU Beta pectin, lot 30003, produced by CPKelco, Germany GmbH, Grossenbrode, Germany) and the enzyme was Flavorzyme 500L TM from Novozymes, Denmark, Batch no. HPN01200 with an activity of 500 LAPU/g.
- pectic substance was derived from orange (Batch no. 1001-69-1 , produced by CPKelco, Limeira, Brasil) and the enzyme was Enzeco Pectinase PL lyase from Enzyme Development Corporation, Batch no. S-11677, Activity 26 U/mi.
- microcapsules were prepared in accordance with the following recipe:
- the oily mixture was added to the aqueous solution of pectin, sugar and sodium ascorbate under slow agitation and then stirred vigorously at 10.000 rpm by Ultra Turrax (Ultra Turrax T50) for 60 minutes at 65 °C.
- the final emulsion was diluted with 975 ml 65 °C water to a viscosity of 150 cP (measured by Brookfield Viscometer type HAT, spindle HA1 ).
- the mean oil droplet size was measured to be 1.40 ⁇ m (Malvern Mastersizer Long bed ver. 2.19, focal length 45 mm, beam length 2.4 mm). Subsequently the emulsion was atomized in a spray tower, where the droplets were covered with starch and dried.
- the stability of the product was investigated as follows: Approximately 0.2 gram product was weighed and placed in a small open glass container (15 x 10 mm) and kept at 25°C/60% R.H. and at 40°C/75% R.H. for 3 weeks. Samples were analyzed at start, after 7.14 and 21 days for potency. The results obtained are given below:
- Example 10 92.9 grams of Collupulin modified sugar beet pectin prepared as described in Example 1 and 797.0 grams of saccharose were dissolved in 1.0 1 water at 65 °C in an emulsion tank and 12.6 grams of sodium ascorbate added. A mixture of 400.0 grams Vitamin A palmitate 1.7 million lU/g and 20.4 grams DL- ⁇ -tocopherol was heated to 65 °C in a beaker. The oily mixture was added to the aqueous solution of modified pectin, sugar and sodium ascorbate under slow agitation and then stirred vigorously at 10.000 rpm by Ultra Turrax (Ultra Turrax T50) for 60 minutes at 65 °C.
- Ultra Turrax Ultra Turrax
- the final emulsion was diluted with 1000 ml 65 °C water to a viscosity of 155 cP (measured by Brookfield Viscometer type HAT, spindle HA1 ).
- the mean oil droplet size was measured to be 1.09 ⁇ m (Malvern Mastersizer Long bed ver. 2.19, focal length 45 mm, beam length 2.4 mm).
- the emulsion was atomised in a spray tower, where the droplets were covered with starch and dried. Only part of the emulsion was sprayed. This yielded after screening on mesh 30/120 approx.
- the stability of the product was investigated as follows: Approximately 0.2 gram product was weighed and placed in a small open glass container (15 x 10 mm) and kept at 25°C/60% R.H. and at 40°C/75% R.H. for 3 weeks. Samples were analyzed at start, after 7, 14 and 21 days for potency. The results obtained are given below:
- the final emulsion was diluted with 1050 ml 65 °C water to a viscosity of 155 cP (measured by Brookfield Viscometer type HAT, spindle HA1).
- the mean droplet size was measured to be 1.28 ⁇ m (Malvern Mastersizer Long bed ver. 2.19, focal length 45 mm, beam length 2.4 mm).
- the emulsion was atomized in a spray tower, where the droplets were covered with starch and dried. Only part of the emulsion was sprayed. This yielded after screening on mesh 30/120 approx.
- the stability of the product was investigated as follows: Approximately 0.2 gram product was weighed and placed in a small open glass container (15 x 10 mm) and kept at 25°C/60% R.H. and at 40°C/75% R.H. for 3 weeks. Samples were analyzed at start, after 7, 14 and 21 days for potency. The results obtained are given below:
- the final emulsion was diluted with 800 ml 65 °C water to a viscosity of 150 cP (measured by Brookfield Viscometer type HAT, spindle HA1 ).
- the mean oil droplet size was measured to be 1.59 ⁇ m (Malvern Mastersizer Long bed ver. 2.19, focal length 45 mm, beam length 2.4 mm).
- the emulsion was atomized in a spray tower, where the droplets were covered with starch and dried. Only part of the emulsion was sprayed. This yielded after screening on mesh 30/120 approx.
- the stability of the product was investigated as follows: Approximately 0.2 gram product was weighed and placed in a small open glass container (15 x 10 mm) and kept at 25 °C/60% R.H. and at 40 °C/75% R.H. for 3 weeks. Samples were analyzed at start, after 7, 14 and 21 days for potency. The results obtained are given below:
- the final emulsion was diluted with 980 ml 65 °C water to a viscosity of 150 cP (measured by Brookfield Viscometer type HAT, spindle HA1).
- the mean oil droplet size was measured to be 1.64 ⁇ m (Malvern Mastersizer Long bed ver. 2.19, focal length 45 mm, beam length 2.4 mm).
- the emulsion was atomized in a spray tower, where the droplets were covered with starch and dried. Only part of the emulsion was sprayed. This yielded after screening on mesh 30/120 approx.
- the stability of the product was investigated as follows: Approximately 0.2 gram product was weighed and placed in a small open glass container (15 x 10 mm) and kept at 25 °C/60% R.H. and at 40 °C/75% R.H. for 3 weeks. Samples were analyzed at start, after 7, 14 and 21 days for potency. The results obtained are given below:
- the final emulsion showed a viscosity of 155 cP (measured by Brookfield Viscometer type HAT, spindle HA1 ).
- the mean oil droplet size was measured to be 0.83 ⁇ m (Malvern Mastersizer Long bed ver. 2.19, focal length 45 mm, beam length 2.4 mm).
- the emulsion was atomized in a spray tower, where the droplets were covered with starch and dried. Only part of the emulsion was sprayed. This yielded after screening on mesh 30/120 approx.
- the stability of the product was investigated as follows: Approximately 0.2 gram product was weighed and placed in a small open glass container (15 x 10 mm) and kept at 25°C/60% R.H. and at 40°C/75% R.H. for 3 weeks. Samples were analyzed at start, after 7, 14 and 21 days for potency. The results obtained are given below:
- the final emulsion was diluted with 1151 ml 65 °C water to a viscosity of 155 cP (measured by Brookfield Viscometer type HAT, spindle HA1).
- the mean oil droplet size was measured to be 0.83 ⁇ m (Malvern Mastersizer Long bed ver. 2.19, focal length 45 mm, beam length 2.4 mm).
- the emulsion was atomized in a spray tower, where the droplets were covered with starch and dried. Only part of the emulsion was sprayed. This yielded after screening on mesh 30/120 approx.
- the stability of the product was investigated as follows: Approximately 0.2 gram product was weighed and placed in a small open glass container (15 x 10 mm) and kept at 25°C/60% R.H. and at 40°C/75% R.H. for 3 weeks. Samples were analyzed at start, after 7, 14 and 21 days for potency. The results obtained are given below: Potencv: 25°C/60% R.H. 40°C/75% R.H.
- the final emulsion showed a viscosity of 100 cP (measured by Brookfield Viscometer type HAT, spindle HA1 ).
- the mean oil droplet size was measured to be 1.77 ⁇ m (Malvern Mastersizer Long bed ver. 2.19, focal length 45 mm, beam length 2.4 mm).
- the emulsion was atomized in a spray tower, where the droplets were covered with starch and dried. Only part of the emulsion was sprayed. This yielded after screening on mesh 30/120 approx.
- the stability of the product was investigated as follows: Approximately 0.2 gram product was weighed and placed in a small open glass container (15 x 10 mm) and kept at 25°C/60% R.H. and at 40°C/75% R.H. for 3 weeks. Samples were analyzed at start, after 7, 14 and 21 days for potency. The results obtained are given below:
- Flavorzyme modified sugar beet pectin prepared as described in Example 8 and 797.0 grams of saccharose were dissolved in 1.0 I water at 65 °C in an emulsion tank and 12.6 grams of sodium ascorbate added.
- a mixture of 400.0 grams Vitamin A palmitate 1.7 million lU/g and 20.4 grams DL- ⁇ -tocopherol was heated to 65 °C in a beaker.
- the oily mixture was added to the aqueous solution of modified pectin, sugar and sodium ascorbate under slow agitation and then stirred vigorously at 10.000 rpm by Ultra Turrax (Ultra Turrax T50) for 60 minutes at 65 °C.
- the final emulsion was diluted with 1093 ml 65 °C water to a viscosity of 155 cP (measured by Brookfield Viscometer type HAT, spindle HA1 ).
- the mean oil droplet size was measured to be 1.50 ⁇ m (Malvern Mastersizer Long bed ver. 2.19, focal length 45 mm, beam length 2.4 mm).
- the emulsion was atomised in a spray tower, where the droplets were covered with starch and dried. Only part of the emulsion was sprayed. This yielded after screening on mesh 30/120 approx.
- the stability of the product was investigated as follows: Approximately 0.2 gram product was weighed and placed in a small open glass container (15 x 10 mm) and kept at 25°C/60% R.H. and at 40°C/75% R.H. for 3 weeks. Samples were analyzed at start, after 7, 14 and 21 days for potency. The results obtained are given below:
- the mean oil droplet size was measured to be 1.84 ⁇ m (Malvern Mastersizer Long bed ver. 2.19, focal length 45 mm, beam length 2.4 mm). Subsequently the emulsion was atomised in a spray tower, where the droplets were covered with starch and dried. Only part of the emulsion was sprayed. This yielded after screening on mesh 30/120 approx. 1 kg of particulate product with a potency of 313.000 lU/g (The sample was saponified with 50% KOH, 96% ethanol and a 10% sodium ascorbate solution and extracted with heptane. The amount of Vitamin A is measured by HPLC, Hichrom LiChrosorb CN-5, 5 ⁇ l, 250 mm x 4.0 mm against an external standard).
- the stability of the product was investigated as follows: Approximately 0.2 gram product was weighed and placed in a small open glass container (15 x 10 mm) and kept at 25°C/60% R.H. and at 40°C/75% R.H. for 3 weeks. Samples were analyzed at start, after 7, 14 and 21 days for potency. The results obtained are given below:
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicinal Preparation (AREA)
- General Preparation And Processing Of Foods (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Cosmetics (AREA)
- Jellies, Jams, And Syrups (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Abstract
Description
Claims
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/474,432 US20040170693A1 (en) | 2001-04-10 | 2002-04-10 | Microcapsules |
| DK02761877T DK1377180T3 (en) | 2001-04-10 | 2002-04-10 | Microcapsules |
| DE60222106T DE60222106T2 (en) | 2001-04-10 | 2002-04-10 | MICRO CAPSULES |
| EP02761877A EP1377180B1 (en) | 2001-04-10 | 2002-04-10 | Microcapsules |
| JP2002580739A JP2004529760A (en) | 2001-04-10 | 2002-04-10 | Micro capsule |
| NO20034547A NO324980B1 (en) | 2001-04-10 | 2003-10-09 | Microcapsules, processes for the preparation of such as well as products which include said microcapsules. |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200100594 | 2001-04-10 | ||
| DKPA200100594 | 2001-04-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2002082924A1 true WO2002082924A1 (en) | 2002-10-24 |
Family
ID=8160431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/DK2002/000238 Ceased WO2002082924A1 (en) | 2001-04-10 | 2002-04-10 | Microcapsules |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040170693A1 (en) |
| EP (1) | EP1377180B1 (en) |
| JP (1) | JP2004529760A (en) |
| CN (1) | CN1236692C (en) |
| AT (1) | ATE371376T1 (en) |
| DE (1) | DE60222106T2 (en) |
| DK (1) | DK1377180T3 (en) |
| ES (1) | ES2288558T3 (en) |
| NO (1) | NO324980B1 (en) |
| WO (1) | WO2002082924A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006016713A1 (en) * | 2004-08-11 | 2006-02-16 | Ajinomoto Co., Inc. | Microcapsule using pectin as wall material |
| JPWO2006016685A1 (en) * | 2004-08-11 | 2008-05-01 | 味の素株式会社 | Method for producing capsinoid-containing microcapsules |
| JP2011177183A (en) * | 2003-01-31 | 2011-09-15 | Dsm Ip Assets Bv | Novel composition comprising carotenoid |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7497623B2 (en) | 2002-02-27 | 2009-03-03 | Pactiv Corporation | Packages with active agents |
| SI22342A (en) * | 2007-10-04 | 2008-02-29 | Vitiva Proizvodnja In Storitve D.D. | ANTIOXIDATIVE AND ANTIMICROBIOLOGICAL PROTEIN OF MASSCOB AND MASSCOBO-CONTENTS OF FOODS WITH MONTHLY EXTRACTS OF ORTHNATES AND VEGETABLES |
| EP2213715A1 (en) | 2009-02-02 | 2010-08-04 | The Procter & Gamble Company | Liquid hand dishwashing detergent composition |
| WO2012074588A2 (en) | 2010-08-30 | 2012-06-07 | President And Fellows Of Harvard College | Shear controlled release for stenotic lesions and thrombolytic therapies |
| US20130251855A1 (en) * | 2012-03-21 | 2013-09-26 | Pepsico, Inc. | Aqueous product comprising oil-containing microcapsules and method for the manufacture thereof |
| CN107594597B (en) * | 2017-07-31 | 2020-05-12 | 浙江新和成股份有限公司 | Fat-soluble nutrient microcapsule and preparation method thereof |
| CN110742278B (en) * | 2019-10-26 | 2022-09-13 | 大连医诺生物股份有限公司 | Vegetable protein system oil microcapsule powder and preparation method thereof |
| CN110801021A (en) * | 2019-11-15 | 2020-02-18 | 江苏独角兽生物科技有限公司 | Method for embedding intestinal composite probiotics by using modified pectin |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0332027A1 (en) * | 1988-03-11 | 1989-09-13 | National Starch and Chemical Corporation | Modified starch emulsifier characterized by shelf stability |
| EP0580252A2 (en) * | 1992-07-20 | 1994-01-26 | Quest International B.V. | Improvements in or relating to pectin methyl esterase |
| WO1995002044A1 (en) * | 1993-07-06 | 1995-01-19 | Novo Nordisk A/S | An enzyme with protease activity |
| US5585256A (en) * | 1992-03-27 | 1996-12-17 | Novo Nordisk A/S | Aspergillus aculeatus rhamnogalacturon acetyl esterases, DNA sequences encoding the enzymes and methods of use thereof |
| US5639494A (en) * | 1992-11-30 | 1997-06-17 | Gist-Brocades, N.V. | Pectinesterase in the treatment of fruit and vegetables |
| WO1998028991A2 (en) * | 1996-12-11 | 1998-07-09 | Gist-Brocades B.V. | Cloudy fruit juices and methods for making same |
| WO2000017368A1 (en) * | 1998-09-24 | 2000-03-30 | Danisco A/S | Orange fruit pectinacetylesterase |
| WO2000058367A1 (en) * | 1999-03-31 | 2000-10-05 | Hercules Incorporated | Pectin having reduced calcium sensitivity |
| WO2000070967A1 (en) * | 1999-05-21 | 2000-11-30 | Chr. Hansen A/S | A colouring substance composition and a method of manufacturing same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997027221A1 (en) * | 1996-01-26 | 1997-07-31 | Novo Nordisk A/S | Enzymatic gelling of polymeric materials |
| US5929051A (en) * | 1998-05-13 | 1999-07-27 | Carrington Laboratories, Inc. | Aloe pectins |
-
2002
- 2002-04-10 EP EP02761877A patent/EP1377180B1/en not_active Expired - Lifetime
- 2002-04-10 US US10/474,432 patent/US20040170693A1/en not_active Abandoned
- 2002-04-10 DK DK02761877T patent/DK1377180T3/en active
- 2002-04-10 CN CNB028080882A patent/CN1236692C/en not_active Expired - Fee Related
- 2002-04-10 JP JP2002580739A patent/JP2004529760A/en active Pending
- 2002-04-10 WO PCT/DK2002/000238 patent/WO2002082924A1/en not_active Ceased
- 2002-04-10 AT AT02761877T patent/ATE371376T1/en not_active IP Right Cessation
- 2002-04-10 DE DE60222106T patent/DE60222106T2/en not_active Expired - Fee Related
- 2002-04-10 ES ES02761877T patent/ES2288558T3/en not_active Expired - Lifetime
-
2003
- 2003-10-09 NO NO20034547A patent/NO324980B1/en unknown
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0332027A1 (en) * | 1988-03-11 | 1989-09-13 | National Starch and Chemical Corporation | Modified starch emulsifier characterized by shelf stability |
| US5585256A (en) * | 1992-03-27 | 1996-12-17 | Novo Nordisk A/S | Aspergillus aculeatus rhamnogalacturon acetyl esterases, DNA sequences encoding the enzymes and methods of use thereof |
| EP0580252A2 (en) * | 1992-07-20 | 1994-01-26 | Quest International B.V. | Improvements in or relating to pectin methyl esterase |
| US5639494A (en) * | 1992-11-30 | 1997-06-17 | Gist-Brocades, N.V. | Pectinesterase in the treatment of fruit and vegetables |
| WO1995002044A1 (en) * | 1993-07-06 | 1995-01-19 | Novo Nordisk A/S | An enzyme with protease activity |
| WO1998028991A2 (en) * | 1996-12-11 | 1998-07-09 | Gist-Brocades B.V. | Cloudy fruit juices and methods for making same |
| WO2000017368A1 (en) * | 1998-09-24 | 2000-03-30 | Danisco A/S | Orange fruit pectinacetylesterase |
| WO2000058367A1 (en) * | 1999-03-31 | 2000-10-05 | Hercules Incorporated | Pectin having reduced calcium sensitivity |
| WO2000070967A1 (en) * | 1999-05-21 | 2000-11-30 | Chr. Hansen A/S | A colouring substance composition and a method of manufacturing same |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011177183A (en) * | 2003-01-31 | 2011-09-15 | Dsm Ip Assets Bv | Novel composition comprising carotenoid |
| WO2006016713A1 (en) * | 2004-08-11 | 2006-02-16 | Ajinomoto Co., Inc. | Microcapsule using pectin as wall material |
| JPWO2006016685A1 (en) * | 2004-08-11 | 2008-05-01 | 味の素株式会社 | Method for producing capsinoid-containing microcapsules |
Also Published As
| Publication number | Publication date |
|---|---|
| NO20034547D0 (en) | 2003-10-09 |
| CN1501776A (en) | 2004-06-02 |
| NO324980B1 (en) | 2008-01-14 |
| DE60222106D1 (en) | 2007-10-11 |
| CN1236692C (en) | 2006-01-18 |
| DK1377180T3 (en) | 2007-12-27 |
| ATE371376T1 (en) | 2007-09-15 |
| NO20034547L (en) | 2003-12-10 |
| JP2004529760A (en) | 2004-09-30 |
| US20040170693A1 (en) | 2004-09-02 |
| EP1377180B1 (en) | 2007-08-29 |
| ES2288558T3 (en) | 2008-01-16 |
| EP1377180A1 (en) | 2004-01-07 |
| DE60222106T2 (en) | 2007-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rutz et al. | Microencapsulation of palm oil by complex coacervation for application in food systems | |
| TWI437962B (en) | Microencapsulation composition, preparation method thereof, use method and product thereof | |
| EP1713575B1 (en) | Aqueous dispersion and its use | |
| EP1377180B1 (en) | Microcapsules | |
| US20230338298A1 (en) | Plant protein-based microcapsules | |
| EP2173321A2 (en) | Tablettable formulations of lipophilic health ingredients | |
| AU2008340061A1 (en) | Microcapsules comprising a fat -soluble active substance | |
| US20070141165A1 (en) | Method for Manufacturing Microcapsules Containing Capsinoid | |
| Miceli-Garcia | Pectin from apple pomace: extraction, characterization, and utilization in encapsulating alpha-tocopherol acetate | |
| Gallotti et al. | Application of Pleurotus ostreatus β-glucans for oil–in–water emulsions encapsulation in powder | |
| US6146671A (en) | Method and protecting heat-or oxygen-labile compounds to preserve activity and bioavailability | |
| US6423346B1 (en) | Fish gelatinous composition for use as an ingredient in tablets | |
| Altuntas et al. | Enhanced oxidative stability and bioaccessibility of sour cherry kernel byproducts encapsulated by complex coacervates with different wall matrixes by spray-and freeze-drying | |
| EP1105099B1 (en) | Fish gelatinous composition for use as an ingredient in tablets | |
| CA2993472C (en) | Formulation of glucosinolates and myrosinase | |
| WO2014159051A1 (en) | Stable bioactive substances and methods of making | |
| WO2008077401A1 (en) | Reactive powdering | |
| Ling et al. | In Vitro Release Study of Freeze-Dried and Oven-Dried Microencapsulated Kenaf Seed Oil. | |
| WO2008077402A1 (en) | Microcapsules | |
| AU6165599A (en) | Method of protecting heat- or oxygen-labile compounds to preserve activity and bioavailability | |
| Ling HueWan et al. | In vitro release study of freeze-dried and oven-dried microencapsulated kenaf seed oil. | |
| Forssell et al. | Potential use of carbohydrates as stabilizers and delivery vehicles of bioactive substances in foods | |
| WO2002082923A1 (en) | Modified pectic substance | |
| JP3377560B2 (en) | Method for solidifying polyunsaturated fatty acids | |
| WO2002082922A1 (en) | Modified pectic substance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2002580739 Country of ref document: JP Ref document number: 028080882 Country of ref document: CN |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2002761877 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 2002761877 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 10474432 Country of ref document: US |
|
| WWG | Wipo information: grant in national office |
Ref document number: 2002761877 Country of ref document: EP |









